Announced Fri, 15 May · 15:09 IST

Outcome of Board Meeting held on May 15, 2026

Revenue Growth 20pctPat Growth 25pctEbitda Margin CompressionNegative Operating CashflowResults View source PDF

DMCC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.4%1-day move
₹322.90
prior close
₹321.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.2-4.0-3.8-3.4-8.9-12.0-14.7-13.8-15.4-24.4-20.0-19.2
Up moveDown movePending
AI summary

DMCC Speciality Chemicals reported strong full-year results for FY2026 ending March 31. Net sales grew 34.8% to Rs 58,150.46 lakhs from Rs 43,123.19 lakhs in FY2025. Net profit increased 26.9% to Rs 2,733.18 lakhs from Rs 2,153.97 lakhs, with EPS rising to Rs 10.96 from Rs 8.64. The board recommended a final dividend of Rs 2.50 per share (25%). EBITDA margin compressed from ~13.5% to ~11% due to raw material costs rising 58.6%, outpacing revenue growth. Operating cash flow turned negative at Rs -1,791.48 lakhs (vs +Rs 3,799.57 lakhs) due to inventory build-up of Rs 4,930 lakhs and higher receivables. Statutory auditors issued an unmodified (clean) opinion.

Likely market impact

Strong revenue and profit growth demonstrate robust demand, though margin pressure and negative operating cash flow warrant monitoring. Clean audit opinion and dividend signal financial stability, but rising working capital needs and short-term borrowings (up 6.5x to Rs 4,962 lakhs) may concern investors focused on cash flow quality.